FAQ
Frequently asked questions
Clear answers about wallet credit, usage, subscriptions, and how Tycoon charges for work.
Is every telehealth brand launching in 2025-2026 actually solo-founded?
No, but the pattern is surprisingly common in specific sub-segments. The clearest examples are in GLP-1 cash-pay, where a single operator can plug into a telehealth orchestrator and a pharmacy network on day one. Categories that require in-house licensed providers (complex mental health, surgery, insurance-billed primary care) still require more infrastructure and headcount. The generalization is: wherever 'licensed service as a partner' is available, solo telehealth is possible. Wherever it is not, it is not.
How can a solo founder realistically run a $400M+ telehealth business?
By not doing the work a traditional $400M telehealth business does. Solo founders do not run clinics, operate pharmacies, or employ large customer service teams. They operate a funnel: creative, ad ops, landing page, intake, and hand-off. Everything downstream is outsourced to partners who already do it at scale. Matthew Gallagher himself has publicly stated that ChatGPT, Claude, and Grok handle most of what used to be a marketing and ops department. The math works because the operator does 1-2% of the actual work of the business and collects the equity upside.
What does the FDA warning letter against Medvi mean for the category?
It means the cash-pay GLP-1 wave has matured fast enough to draw real regulatory attention. The December 2025 warning letter flagged specific claims and labeling issues (for example, text implying Medvi itself was the compounder when it is not, or marketing that equated Medvi's compounded product with Wegovy and Ozempic). For the category broadly, this signals that marketing claims, prescriber oversight, and pharmacy disclosures will be the next battleground. Solo founders who want to survive must invest in compliance as rigorously as they invest in paid acquisition.
Can this pattern move to other verticals?
It is already starting to. Cash-pay primary care concierge services, online mental-health support, cosmetic dermatology, and certain supplement and nutrition categories are seeing solo-founded experiments with similar outsourcing patterns. Outside healthcare, the closest analogs are in legal services (LLC formation, trademark filing), tax and accounting (for small businesses), and some financial advice — each with its own regulator problem. The unlock is always the same: a 'platform partner' that handles the licensed part so the operator can focus on funnel and funding.
What would a Series A-backed competitor do to stop a solo Medvi-style brand?
Three things, if they were competent. First, aggressively defend brand search and review sites so that a Medvi-like newcomer cannot hijack their traffic. Second, ship faster cross-channel creative — the solo brands are winning on creative volume, and funded teams can technically match or exceed that with the right structure. Third, work with regulators proactively to establish clinical governance standards that small operators cannot meet. Hims and Ro are attempting versions of all three; the outcome over the next 18 months will determine whether the category stays solo-operable at scale.